REGENXBIO (RGNX) R&D/CAPEX US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 618.9% | 215.5% | 789.1% | 2 332% | 8 105% | ||||
Changes by years, y/y, % | -441pp | -403pp | -216pp | +1 543pp | +29.9% |
REGENXBIO. R&D/CAPEX, %
REGENXBIO. R&D/CAPEX, changes, pp
REGENXBIO (RGNX) R&D/CAPEX US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
R&D/CAPEX, % | 4 043% | 4 560% | 9 096% | 9 455% | 16 696% | 8 105% | ||
Changes by years, y/y, % | +2 790pp | +3 417pp | +7 881pp | +7 131pp | +12 653pp | |||
Changes by quarters, q/q, % | +1 719pp | +517pp | +4 536pp | +359pp | +7 241pp |